Tag Archives: Supreme Court

USPTO Subject Matter Eligibility Guidance – 9th May Forum – Outcome and Opportunities

Posted on May 16, 2014 by Warren Woessner

Guest Post from Paul Cole, Lucas & Co., UK As noted in postings in this and other blogs, controversy has been generated by the publication of new USPTO patent eligibility guidance for laws of nature, natural products and natural phenomena (Andrew … Continue reading →

Posted in Forum | Tagged , , , , , , , | 1 Comment

Dolly Led to Slaughter – Part II

Posted on May 9, 2014 by Warren Woessner

As I read and re-read In re Roslin, App. No.  2013-1407 (Fed. Cir., May 8, 2014), before going across the street to “testify” at the PTO 101 Forum, I was struck by how the logical pathway chosen by the panel … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

Section 101 Fells Dolly: What Organism Is Next?

Posted on May 9, 2014 by Warren Woessner

On Thursday, a panel of the Fed. Cir. affirmed a board decision refusing a patent claim to an animal prepared by adult cell cloning (a copy is available at the end of this post). Specifically, the patent claims covering “Dolly” … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | 1 Comment

Isolated DNA and the “Hand of Man”

Posted on April 28, 2014 by Warren Woessner

Editors Notes: Apart from a fine survey of the case law on patent-eligibility of not-so natural products, Paul Cole suggests that, in view of the incomplete and/or indirect description of the BRACA sequences that Myriad claimed, there may well be … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment